Contact HealthDay
Tel: 203.855.1400 or E-mail

News By Specialty

Allergy
Anesthesiology
Cardiology
Cosmetic Surgery
Critical Care
Dermatology
Diabetes & Endocrinology
Emergency Medicine
Family Practice
Gastroenterology
Geriatrics
Hematology & Oncology
HIV & AIDS
Infectious Disease
Internal Medicine
Nephrology
Neurology
Nursing
OBGYN & Women's Health
Ophthalmology
Orthopedics
Otolaryngology
Pain Management
Pathology
Pediatrics
Pharmacy
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Follow us on:

    


e-Healthcare Leadership Awards


Imeglimin Beneficial As Add-On to Metformin in T2DM
As add-on therapy, new oral agent improves glycemic control; generally well tolerated
This article is older than one year and is no longer available.

Copyright © 2012 HealthDay. All rights reserved.

October 25, 2014

Archive Search

By Keyword:
By Category:
By Topic:

Related Articles

More Attention to CVD Risk Assessment in T1DM Urged

New York City Health Officials Confirm First Ebola Case

Two Biomarkers May Aid Diagnosis of Rhinosinusitis

Pharmacoinvasive STEMI Strategy Best for Smokers, Nonsmokers

FDA Approves New Treatment for Acquired Hemophilia A

Airborne Transmission of Ebola Highly Unlikely